<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1612246425
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DURACAN 150MG CAPSULE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FLUCONAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        150
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, soft
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J02AC01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DuracanTM is one of a group of medicines called &ldquo;antifungals&rdquo;. The active<br />substance is fluconazole.<br />DuracanTM is used to treat infections caused by fungi and may also be<br />used to stop you from getting a candidal infection. The most common<br />cause of fungal infections is a yeast called Candida.<br />Adults<br />You might be given this medicine by your doctor to treat the following<br />types of fungal infections:<br />- Genital thrush (infection of the vagina or penis).<br />- Pitryasis versicolor &amp; Skin infections (e.g. athlete&#39;s foot, ringworm, jock<br />itch, nail infection).<br />- Mucosal thrush (infection affecting the lining of the mouth, throat and<br />denture sore mouth).<br />- Cryptococcal meningitis (a fungal infection in the brain).<br />- Coccidioidomycosis (a disease of the bronchopulmonary system).<br />- Infections caused by Candida and found in the blood stream, body<br />organs (e.g. heart, lungs) or urinary tract.<br />You might also be given Duracan&trade; to:<br />- reduce recurrence of vaginal thrush.<br />- stop mucosal thrush from coming back.<br />- stop cryptococcal meningitis from coming back.<br />- stop you from getting an infection caused by Candida (if your immune<br />system is weak and not working properly).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take DuracanTM if you<br />- are allergic (hypersensitive) to fluconazole, to other medicines you have<br />taken to treat fungal infections or to any of the other ingredients of<br />DuracanTM. The symptoms may include itching, reddening of the skin or<br />difficulty in breathing.<br />- are taking astemizole, terfenadine (antihistamine medicines for<br />allergies).<br />- are taking cisapride (used for stomach upsets).<br />- are taking pimozide (used for treating mental illness).<br />- are taking quinidine (used for treating heart arrhythmia).<br />- are taking erythromycin (an antibiotic for treating infections).<br />Take special care with Duracan&trade;<br />Tell your doctor if you<br />- have liver or kidney problems.<br />- suffer from heart disease, including heart rhythm problems.<br />- have abnormal levels of potassium, calcium or magnesium in your<br />blood.<br />- develop severe skin reactions (itching, reddening of the skin or<br />difficulty in breathing).<br />Taking other medicines<br />Tell your doctor immediately if you are taking astemizole, terfenadine<br />(an antihistamine for treating allergies) or cisapride (used for stomach<br />upsets) or pimozide (used for treating mental illness) or quinidine (used<br />for treating heart arrhythmia) or erythromycin (an antibiotic for treating<br />infections) as these should not be taken with DuracanTM (see section: &ldquo;Do<br />not take Duracan&trade; if you&rdquo;).<br />There are some medicines that may interact with Duracan&trade;. Make sure<br />your doctor knows if you are taking any of the following medicines:<br />- rifampicin or rifabutin (antibiotics for infections).<br />- alfentanil, fentanyl (used as anaesthetic).<br />- amitriptyline, nortriptyline (used as anti-depressant).<br />- amphotericin B, voriconazole (anti-fungal).<br />- medicines that thin the blood to prevent blood clots (warfarin or similar<br />medicines).<br />- benzodiazepines (midazolam, triazolam or similar medicines) used to<br />help you sleep or for anxiety.<br />- carbamazepine, phenytoin (used for treating fits).<br />- nifedipine, isradipine, amlodipine, felodipine and losartan (for<br />hypertension- high blood pressure).<br />- ciclosporin, everolimus , sirolimus or tacrolimus (to prevent transplant<br />rejection).<br />- cyclosphosphamide, vinca alkaloids (vincristine, vinblastine or similar<br />medicines) used for treating cancer<br />- halofantrine (used for treating malaria).<br />- statins (atorvastatin, simvastatin and fluvastatin or similar medicines)<br />used for reducing high cholesterol levels.<br />- methadone (used for pain).<br />- celecoxib, flurbiprofen, naproxen, ibuprofen, lornoxicam, meloxicam,<br />diclofenac (Non-Steroidal Anti-Inflammatory Drugs (NSAID)).<br />- oral contraceptives.<br />- prednisolone (steroid).<br />- zidovudine, also known as AZT; saquinavir (used in HIV-infected<br />patients).<br />- medicines for diabetes such as chlorpropamide, glibenclamide, glipizide<br />or tolbutamide.<br />- theophylline (used to control asthma).<br />- vitamin A (nutritional supplement).<br />Please tell your doctor or pharmacist if you are taking or have recently<br />taken any other medicines, including medicines obtained without a<br />prescription.<br />Taking DuracanTM with food and drink<br />You can take your medicine with or without a meal Pregnancy and<br />breast-feeding. Tell your doctor if you are pregnant, trying to become<br />pregnant or breast-feeding. You should not take DuracanTM while you are<br />pregnant or breast-feeding unless your doctor has told you to.<br />Ask your doctor or pharmacist for advice before taking any medicines.<br />Driving and using machines<br />When driving vehicles or using machines, it should be taken into account<br />that occasionally dizziness or fits may occur.<br />Important information about some of the ingredients of DuracanTM<br />This medicine contains a small amount of lactose, if you have been told<br />by your doctor that you have an intolerance to some sugars, please<br />contact your doctor before taking this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take your medicine exactly as your doctor has told you. You<br />should check with your doctor or pharmacist if you are not sure.<br />Swallow the capsule whole with a glass of water. It is best to take your<br />capsules at the same time each day.<br />The usual doses of this medicine for different infections are below:<br />Adult</p><p><img alt="" width="666" height="581" src="data:image/png;base64,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" /></p><p>Adolescents from 12 to 17 years old<br />Follow the dose prescribed by your doctor (either adults or children<br />posology).<br />Doctors sometimes prescribe different doses to these. Always take your<br />medicine exactly as your doctor has told you. You should check with<br />your doctor or pharmacist if you are not sure.&nbsp;</p><p>Elderly<br />The usual adult dose should be given unless you have kidney problems.<br />Patients with kidney problems<br />Your doctor may change your dose, depending on your kidney function.<br />If you take more DuracanTM than you should<br />Taking too many capsules at once may make you unwell. Contact your<br />doctor or your nearest hospital casualty department at once. The<br />symptoms of a possible overdose may include hearing, seeing, feeling and<br />thinking things that are not real (hallucination and paranoid behaviour).<br />Symptomatic treatment (with supportive measures and gastric lavage if<br />necessary) may be adequate.<br />If you forget to take DuracanTM<br />Do not take a double dose to make up for a forgotten dose. If you forget<br />to take a dose, take it as soon as you remember. If it is almost time for<br />your next dose, do not take the dose that you missed.<br />If you have any further questions on the use of this medicine, ask your<br />doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, DuracanTM can cause side effects, although not<br />everybody gets them<br />A few people develop allergic reactions although serious allergic<br />reactions are rare. If you get any of the following symptoms, tell your<br />doctor immediately.<br />- sudden wheezing, difficulty in breathing or tightness in the chest<br />- swelling of eyelids, face or lips.<br />- itching all over the body, reddening of the skin or itchy red spots.<br />- skin rash.<br />- severe skin reactions such as a rash that causes blistering (this can affect<br />the mouth and tongue).<br />Duracan&trade; may affect your liver. The signs of liver problems include:<br />- tiredness.<br />- loss of appetite.<br />- vomiting.<br />- yellowing of your skin or the whites of your eyes (jaundice).<br />If any of these happen, stop taking DuracanTM and tell your doctor<br />immediately.<br />Other side effects:<br />Additionally, if any of the following side effects gets serious, or if you<br />notice any side effects not listed in this leaflet, please tell your doctor or<br />pharmacist.<br />Common side effects which affect 1 to 10 users in 100 are listed below:<br />- headache.<br />- stomach discomfort, diarrhoea, feeling sick, vomiting.<br />- increases in blood tests of liver function.<br />- rash.<br />Uncommon side effects which affect 1 to 10 users in 1,000 are listed<br />below:<br />- reduction in red blood cells which can make skin pale and cause<br />weakness or breathlessness.<br />- decreased appetite.<br />- inability to sleep, feeling drowsy.<br />- fit, dizziness, sensation of spinning, tingling, pricking or numbness,<br />changes in sense of taste.<br />- constipation, difficult digestion, wind, dry mouth.<br />- muscle pain.<br />- liver damage and yellowing of the skin and eyes (jaundice).<br />- wheals, blistering (hives), itching, increased sweating.<br />- tiredness, general feeling of being unwell, fever.<br />Rare side effects which affect 1 to 10 users in 10,000 are listed below:<br />- lower than normal white blood cells that help defend against infections<br />and blood cells that help to stop bleeding.<br />- red or purple discoloration of the skin which may be caused by low<br />platelet count, other blood cell changes.<br />- blood chemistry changes (high blood levels of cholesterol, fats).<br />- low blood potassium.<br />- shaking.<br />- abnormal electrocardiogram (ECG), change in heart rate or rhythm.<br />- liver failure.<br />- allergic reactions (sometimes severe), including widespread blistering<br />rash and skin peeling, severe skin reactions, swelling of the lips or face.<br />- hair loss.<br />If any of the side effects gets serious, or if you notice any side effects not<br />listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children.<br />- Do not store above 30 OC.<br />- Do not use DuracanTM after the expiry date which is stated on the pack<br />after EXP.<br />Medicines should not be disposed of via wastewater or household waste.<br />Ask your pharmacist how to dispose of medicines no longer required.<br />These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><sup>What DuracanTM contains<br />- The active substance is fluconazole.<br />- Each hard capsule contains 150 mg of fluconazole.<br />- The other ingredients are Lactose Monohydrate, Maize Starch,<br />Pregelatinized Starch, Sodium Lauryl Sulfate, Colloidal Silicon Dioxide,<br />Magnesium Stearate, titanium dioxide and brilliant blue FCF<br />(FD&amp;C blue No.1) and gelatin.</sup></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What DuracanTM 150 mg hard capsules look like and contents of the
pack
DuracanTM 150mg Capsules: Blue opaque cap and blue opaque body,
printed 'Jamjoom' on cap in black and 'FL150' on body in red, hard gelatin
capsules, filled with white to off white homogenous powder.
DuracanTM 150 mg come in packs of 1 hard capsule.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer<br />Jamjoom Pharmaceuticals Factory Co.,<br />Jeddah, Makkah Region, Saudi Arabia.<br />Tel: +966-12-6081111 Fax: +966-12-6081222<br />Website: www.jamjoompharma.com<br />Please report adverse drug events to:<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance Centre (NPC):<br />o Fax: +966-11-205-7662<br />o SFDA Call Center: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: https://ade.sfda.gov.sa<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12505705 - Rev. 04/02-10-2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>ھو واحد من مجموعة أدویة تسمى&quot;مضادات الفطریات&quot;. یحتوى على المادة الفعالة &trade; دیوراكان<br />فلوكونازول.<br />یستخدم لعلاج العدوى التى تسببھا الفطریات كما یمكن أن یستخدم لمنع الإصابة &trade; دیوراكان<br />بعدوى المبیضات (الكاندیدا). السبب الأكثر شیوعا للعدوى الفطریة ھو نوع من أنواع الخمائر<br />یسمى &quot;المبیضات&quot;.<br />الكبار<br />قد یصف لك طبیبك ھذا الدواء لعلاج العدوى الفطریة الآتیة:<br />&bull; مرض السلاق التناسلى (عدوى المھبل أو القضیب).<br />&bull; النخالیة المبرقشة وفطریات الجلد (مثل تینیا القدم الریاضیة، مرض السعفة، حكة جوك (حكة<br />اللعب)، عدوى الأظافر).<br />&bull; مرض السلاق المخاطى (العدوى التى تصیب بطانة الفم، الحلق و الأسنان، و تقرح الفم).<br />&bull; التھاب السحایا بالمستخفیات (عدوى فطریة فى المخ).<br />&bull; داء الفطار الكروانى (مرض النظام القصبى الرئوى).<br />&bull; العدوي الناجمة عن المبیضات و المتواجدة فى مجرى الدم و أعضاء الجسم (مثل القلب و<br />الرئتین) أو فى مجرى البول .<br />لك لكى: &trade; أیضا قد یتم وصف دیوراكان<br />&bull; یحد من تكرار الإصابة بمرض السلاق المھبلى.<br />&bull; یمنع عودة الإصابة بالتھاب السحایا بالمستخفیات.<br />&bull; یمنع عودة الإصابة بمرض السلاق المخاطى.<br />&bull; یقیك من الإصابة بالعدوى التى تسببھا المبیضات إذا كان جھازك المناعى ضعیف و لا یعمل<br />بشكل صحیح.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول ديوراكان فى الحالات الآتية:&nbsp;&bull; إذا كنت تعانى من حساسیة لفلوكونازول أو لأى دواء آخر استخدمتھ من قبل لعلاج عدوى<br />فطریة أو لأى من المكونات الأخرى لھذا الدواء. أعراض الحساسیة قد تشمل حكة، إحمرار<br />الجلد أو صعوبة فى التنفس.<br />&bull; أنت تتناول أستیمازول، ترفینادین و(ھى أدویة مضادة للھیستامین تستخدم لعلاج الحساسیة).<br />&bull; أنت تتناول سیثابرید ( یستخدم لعلاج إضطرابات المعدة).<br />&bull; أنت تتناول بیموزید ( یستخدم لعلاج الأمراض العقلیة).<br />&bull; أنت تتناول كینیدین ( یستخدم لعلاج عدم انتظام ضربات القلب).<br />&bull; أنت تتناول إریثرومیسین و ھو مضاد حیوى یستخدم لعلاج العدوى).<br />فى الحالات الآتیة: &trade; أعط عنایة خاصة عند تناول دیوراكان<br />یرجى اخبار الطبیب إذا كنت:<br />&bull; تعانى من مشاكل فى الكبد أو الكلى.<br />&bull; تعانى من مرض فى القلب بما فى ذلك مشاكل ضربات القلب.<br />&bull; لدیك مستویات غیر طبیعیة للبوتاسیوم، الكالسیوم أو الماغنسیوم فى دمك.<br />&bull; تحدث لك تفاعلات جلدیة خطیرة مثل الحكة، إحمرار الجلد أو صعوبة التنفس.<br />تناول أدویة أخرى<br />&bull; یرجى اخبار الطبیب على الفور إذا كنت تتناول أستیمازول، ترفینادین (ھى أدویة مضادة<br />للھیستامین تستخدم لعلاج الحساسیة) أو سیثابرید (یستخدم لعلاج إضطرابات المعدة) أو بیموزید<br />(یستخدم لعلاج الأمراض العقلیة) أو كینیدین (یستخدم لعلاج عدم انتظام ضربات القلب) أو<br />إریثرومیسین (و ھو مضاد حیوى یستخدم لعلاج العدوى) لأنھ لا یجب تناول ھذه الأدویة مع<br />فى الحالات الآتیة&quot;). &trade; انظر إلى الجزء بعنوان &quot; لا تتناول دیوراكان ) &trade; دیوراكان<br />تأكد أن طبیبك یعلم إذا كنت تتناول أى من .&trade; ھناك بعض الأدویة التى قد تتفاعل مع دیوراكان<br />الأدویة الآتیة:<br />&bull; ریفامبیسین أو ریفابیوتین (مضادات حیویة لعلاج العدوى).<br />&bull; ألفنتانیل أو فنتانیل (أدویة مخدرة).<br />&bull; أمیتریبتیلین أو نورتریبتیلین (أدویة مضادة للإكتئاب).<br />&bull; أمفوتیرسین بى أو ڤوریكونازول (أدویة مضادة للفطریات).<br />&bull; الأدویة المانعة لتجلط الدم (مثل الوارفارین أو الأدویة المماثلة).<br />&bull; مركبات البنزودیازیبین (میدازولام، تریازولام أو الأدویة المماثلة) تستخدم لعلاج الأرق و فى<br />المساعدة على النوم.<br />&bull; كاربامازیبیم، فینیتوین (أدویة لعلاج نوبات التشنج).<br />&bull; نیفیدیبین، إثرادیبین، أملودیبین، فیلودیبین و لوسارتان (أدویة لعلاج ارتفاع ضغط الدم).<br />&bull; سیكلوسبورین، إیڤیرولیمس، سیرولیمس أو تاكرولیمس (أدویة لمنع رفض الأعضاء<br />المزروعة).<br />&bull; سیكلوفوسفامید، قلویات فینیكا (مثل فینكریستین، فینبلاستین أو الأدویة المماثلة) و التى تستخدم<br />لعلاج السرطان.<br />&bull; ھالوفانترین (یستخدم للعلاج الملاریا).<br />&bull; الاستاتینات (مثل أتورڤاستاتین، سیمڤاستاتین، فلوڤاستاتین أو الأدویة المماثلة) التى تستخدم<br />لخفض مستوى الكولیستیرول فى الدم.<br />&bull; المیثادون (یستخدم لتخدیر الآلام).<br />&bull; سیلیكوكسیب، فلوبیبروفین، نابروكسین، إیبوبروفین، میلوكسیكام، لورونوكسیكام، دیكلوفیناك<br />(مضادات الإلتھاب غیر الستیروئیدیة).<br />&bull; موانع الحمل التى تؤخذ عن طریق الفم.<br />&bull; بریدنیسولون (ستیروید).<br />&bull; زیدوفودین ، ساكوینافیر (أدویة تستخدم لعلاج فیرس نقص المناعة البشریة).<br />&bull; أدویة داء السكرى (مثل كلوربرومید، جلیبینكلامید، جلیبیذید أو تولبیوتامید).<br />&bull; ثیوفیللین (یستخدم للربو).<br />&bull; فیتامین أ (مكمل غذائي).<br />یرجى إخبار الطبیب أو الصیدلى إذا كنت تتناول أو تناولت مؤخرا أي أدویة أخرى. ھذا یشمل<br />الأدویة التى یمكنك شراؤھا بدون وصفة طبیة.<br />مع الطعام والشراب &trade; تناول دیوراكان<br />مع أو بدون الطعام. &trade; یمكنك تناول دیوراكان<br />الحمل و الرضاعة<br />یرجى اخبار الطبیب فى حالة كونك حاملاً ، تخطیطن للحمل أو إذا كنتِ مرضعة.<br />أثناء الحمل إلا إذا طلب منك طبیبك أن تستمرى فى تناولھ أثناء &trade; لا یجب أن تتناولى دیوراكان<br />الحمل.<br />استشیرى الطبیب أو الصیدلى قبل أن تتناولى أى دواء أثناء الحمل.<br />القیادة و تشغیل الآلات<br />عند القیادة أو تشغیل الآلات یجب الأخذ فى الإعتبار أنھ فى بعض الأحیان قد یحدث دوار أو<br />تشنجات.<br />&trade; معلومة ھامة عن بعض مكونات دیوراكان<br />ھذا الدواء یحتوى على كمیة صغیرة من اللاكتوز، إذا ما تم إخبارك بأنھ لا یمكنك ھضم بعض<br />السكریات ، تحدث إلى طبیبك قبل البدء فى تناول ھذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قم دائما بتناول ھذا الدواء كما أخبرك طبیبك تماما. یجب أن تستشیر طبیبك أو الصیدلي إذا كنت<br />غیر متأكد من كیفیة الاستخدام.<br />قم ببلع الكبسولة كاملة مع كوب من الماء. من المفضل أن تاخذ كبسولتك فى نفس الوقت كل یوم.<br />الجرعات المعتادة لھذا الدواء لعلاج العدوى المختلفة مذكورة بالأسفل:<br />الكبار.</p><p>&nbsp;</p><p><img src="data:image/png;base64,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" alt="" width="425" height="390" vspace="0" hspace="0" border="0" style="width:425px;height:390px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p><p>المراھقین من ۱۲ إلى ۱۷ عام<br />اتبع الجرعات الموصوفة من قبل الطبیب.<br />قد یصف الأطباء أحیانا جرعات مختلفة لھذه. دائما تناول الدواء الخاص بك تماماً كما أخبرك<br />طبیبك. یجب أن تستشیر الطبیب أو الصیدلي إذا كنت غیر متأكد.</p><p>المسنین<br />یُعطى نفس الجرعة المعتادة للكبار إلا إذا كنت تعانى مشاكل فى الكلى.<br />المرضى المصابون بمشاكل فى الكلى<br />قد یقوم طبیبك بتغییر جرعتك و ذلك بناءا على وظائف الكلى لدیك.<br />أكثر مما ینبغى: &trade; إذا كنت تتناول دیوراكان<br />تناول العدید من الكبسولات دفعة واحدة قد یجعلك تشعر بالتعب. اتصل بطبیبك أو بقسم الحوادث<br />بأقرب مستشفى لك على الفور. الأعراض المحتملة للجرعة الزائدة قد تشمل سماع، رؤیة،<br />شعور أو تفكیر بأشیاء غیر حقیقیة (الھلوسة وسلوك جنون العظمة). علاج الأعراض (مع<br />التدابیر الداعمة و غسیل المعدة إذا لزم الأمر) قد یكون كافیا.<br />:&trade; إذا نسیت أن تتناول دیوراكان<br />لا تتناول جرعة مضاعفة لتعویض الجرعة المنسیة.<br />إذا نسیت جرعة قم بتناولھا بمجرد تذكرك. إذا كان وقت الجرعة التالیة قد حان ، لا تتناول<br />الجرعة المنسیة.<br />إذا كان لدیك أیة أسئلة أخرى عن استخدام ھذا الدواء ، إسأل الطبیب أو الصیدلى .</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>لكنھا لا &trade; كما ھو الحال مع جمیع الأدویة ، من المحتمل ظھور أعراض جانبیة مع دیوراكان<br />تصیب كل الأشخاص.<br />لدى بعض الأشخاص قد یحدث ردود فعل تحسسیة بالرغم من ذلك فإن ردود الفعل التحسسیة<br />الشدیدة تكون نادرة الحدوث. إذا شعرت بإحدى الأعراض التالیة یرجى اخبار الطبیب على<br />الفور:<br />&bull; أزیز مفاجىء فى الصدر، صعوبة فى التنفس أو الشعور بوخز فى الصدر.<br />&bull; انتفاخ الجفون، الوجھ أو الشفتین.<br />&bull; حكة فى جمیع أنحاء الجسم، إحمرار الجلد أو ظھور بقع حمراء فى الجلد مثیرة للحكة.<br />&bull; طفح جلدى.<br />&bull; ردود فعل تحسسیة شدیدة تصیب الجلد مثل الطفح الجلدى الذى یسبب تقرح الجلد (ھذا قد<br />یصیب الفم و اللسان).<br />قد یؤثر على الكبد. علامات الإصابة بمشاكل الكبد تشمل: &trade; دیوراكان<br />&bull; الإرھاق.<br />&bull; فقدان الشھیھ.<br />&bull; القىء.<br />&bull; إصفرار الجلد أو العین (الیرقان).<br />و اخبر طبیبك على &trade; إذا شعرت بأى من الأعراض السابق ذكرھا، توقف عن تناول دیوراكان<br />الفور.<br />الأعراض الجانبیة الأخرى:<br />بالإضافة إلى ذلك ، إذا أصبحت إحدى الآثار الجانبیة التالیة خطیرة أو ظھرت آثار جانبیة جدیدة<br />لم تذكر في ھذه النشرة یرجى اخبار الطبیب أو الصیدلي .<br />أعراض جانبیة شائعة تصیب ۱ إلى ۱۰ أشخاص من كل ۱۰۰ شخص یستخدم ھذا الدواء:<br />&bull; صداع.<br />&bull; إضطراب المعدة، إسھال، غثیان، قىء.<br />&bull; زیادة فى فحوصات الدم الخاصة بوظائف الكبد.<br />&bull; طفح جلدى.<br />أعراض جانبیة غیر شائعة تصیب ۱ إلى ۱۰ أشخاص من كل ۱۰۰۰ شخص یستخدم ھذا<br />الدواء:<br />&bull; نقص خلایا الدم البیضاء مما قد یسبب شحوب الجلد و الضعف أو ضیق التنفس.<br />&bull; فقدان الشھیھ.<br />&bull; عدم القدرة على النوم، الشعور بالدوار.<br />&bull; تشنجات، الدوار، الشعور بالوخز أو التنمیل ، تغیر فى حاسة التذوق.<br />&bull; إمساك، عسر الھضم، انتفاخ البطن، جفاف الفم.<br />&bull; ألم العضلات.<br />&bull; ضرر الكبد و إصفرار الجلد و العینین (الیرقان).<br />&bull; حكة ، تقرح الجلد، زیادة التعرق.<br />&bull; إرھاق و الشعور العام بالتعب، حمى.<br />أعراض جانبیة غیر شائعة تصیب ۱ إلى ۱۰ أشخاص من كل ۱۰۰۰۰ شخص یستخدم ھذا<br />الدواء:<br />&bull; نقص خلایا الدم البیضاء التى تساعد فى حمایة الجسم من الإصابة بالعدوى و خلایا الدم التى<br />تساعد فى وقف النزیف.<br />&bull; تغیر لون الجلد إلى اللون الأحمر أو الأرجوانى الناجم عن انخفاض عدد الصفائح الدمویة و<br />غیرھا من التغیرات فى خلایا الدم.<br />&bull; تغیر فى كیمیاء الدم (زیادة مستویات الكولیسترول و الدھون فى الدم).<br />&bull; انخفاض مستوى البوتاسیوم فى الدم.<br />&bull; إرتجاف.<br />&bull; تغیر فى مخطط كھربیة القلب.<br />&bull; فشل الكبد.<br />&bull; ردود فعل تحسسیة ( فى بعض الأحیان تكون حادة ) تشمل انتشار الطفح الجلدى و قرح الجلد<br />و تقشر الجلد ، تفاعلات جلدیة شدیدة، تورم الشفتین أو الوجھ.<br />&bull; فقدان الشعر.<br />إذا وصلت أحد الآثار الجانبیة لھذا الدواء لمرحلة الخطر أو ظھرت آثار جانبیة جدیدة لم تذكر في<br />ھذه النشرة یرجى اخبار الطبیب أو الصیدلي .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; یحفظ بعیداً عن متناول و مرأي الأطفال.<br />م. &ordm; &bull; یحفظ فى درجة حرارة لا تزید عن ۳۰<br />.EXP &bull; لا تتناول ھذا الدواء بعد انتھاء فترة الصلاحیة المكتوبة على العلبة بعد كلمة<br />اسأل الصیدلي عن طریقة التخلص من الأدویة التي لم تعد بحاجة إلیھا. لا ینبغي التخلص من<br />الأدویة عبر إلقائھا فى بالوعات الصرف أو فى مخلفات المنزل . ستساعد ھذه التدابیر في حمایة<br />البیئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&trade; ما ھي مكونات دیوراكان<br />المادة الفعالة ھى فلوكونازول.<br />كل كبسولة صلبة تحتوى على ۱٥۰ ملجم فلوكونازول.<br />المكونات الأخرى ھي: مونوھیدرات اللاكتوز ، نشا الذرة ، نشا مسبق التجلتن ، كبریتات لوریل<br />الصودیوم ، ثاني أكسید السیلیكون الغرواني ، ستیرات المغنیسیوم ، ثاني أكسید التیتانیوم، لون<br />أزرق رقم . ۱) و جیلاتین. FD&amp;C) FCF أزرق</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">۰ ملجم ذات جزء علوي أزرق غیر شفاف والجزء الآخر السفلي &trade; كبسولات دیوراكان<br />&#39;FL باللون الأسود على الجزء العلوي وكلمة &#39; 150 &#39;Jamjoom&#39; أزرق غیر شفاف. مطبوع كلمة<br />على الجزء السفلي باللون الأحمر، كبسولات جیلاتینیة صلبة مملوءة ببودرة متجانسة لونھا<br />أبیض إلي مائل للأبیض</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>اسم وعنوان مالك رخصة التسویق و المصنع:<br />شركة مصنع جمجوم للأدویة ،<br />جدة، منطقة مكة، المملكة العربیة السعودیة.<br />+۹٦٦-۱۲- الھاتف: ٦۰۸۱۱۱۱<br />+۹٦٦-۱۲- فاكس: ٦۰۸۱۲۲۲<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبیھ:<br />&bull; المملكة العربیة السعودیة:<br />:(NPC) المركز الوطني للتیقظ الدوائي<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />مركز اتصال الھیئة العامة للغذاء والدواء: ۱۹۹۹۹ o<br />npc.drug@sfda.gov.sa : برید إلكتروني o<br />https://ade.sfda.gov.sa : الموقع الالكتروني o</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12505705 - Rev. 04/02-10-2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Duracan 150 mg Capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains fluconazole 150mg.
For full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hard gelatin capsule.
Blue opaque cap and blue opaque body, printed 'Jamjoom' on cap in black and
'FL150' on body in red, size '1' hard gelatin capsules, filled with white to off white
homogenous powder.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Duracan is indicated in the following fungal infections (see section 5.1).<br />Duracan is indicated in adults for the treatment of:<br />&bull; Cryptococcal meningitis (see section 4.4).<br />&bull; Coccidioidomycosis (see section 4.4).<br />&bull; Invasive candidiasis.<br />&bull; Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria<br />and chronic mucocutaneous candidiasis.<br />&bull; Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical<br />treatment are insufficient.<br />&bull; Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.<br />&bull; Candidal balanitis when local therapy is not appropriate.<br />&bull; Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor<br />and dermal candida infections when systemic therapy is indicated.<br />&bull; Tinea unguinium (onychomycosis) when other agents are not considered appropriate</p><p>&bull; Duracan is indicated in adults for the prophylaxis of:<br />&bull; Relapse of cryptococcal meningitis in patients with high risk of recurrence.<br />&bull; Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV<br />who are at high risk of experiencing relapse.<br />&bull; To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).<br />&bull; Prophylaxis of candidal infections in patients with prolonged neutropenia (such as<br />patients with haematological malignancies receiving chemotherapy or patients<br />receiving Hematopoietic Stem Cell Transplantation (see section 5.1)).<br />Duracan is indicated in term newborn infants, infants, toddlers, children, and adolescents<br />aged from 0 to 17 years old:<br />Duracan is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal),<br />invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in<br />immunocompromised patients. Duracan can be used as maintenance therapy to prevent<br />relapse of cryptococcal meningitis in children with high risk of reoccurrence (see section 4.4).<br />Therapy may be instituted before the results of the cultures and other laboratory studies are<br />known; however, once these results become available, anti-infective therapy should be<br />adjusted accordingly.<br />Consideration should be given to official guidance on the appropriate use of antifungals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />The dose should be based on the nature and severity of the fungal infection. Treatment of<br />infections requiring multiple dosing should be continued until clinical parameters or<br />laboratory tests indicate that active fungal infection has subsided. An inadequate period of<br />treatment may lead to recurrence of active infection.</p><table cellspacing="0" cellpadding="2" border="1" style="width:691px"><tbody><tr><td colspan="2" rowspan=""><p><strong><u>Indications</u></strong></p></td><td colspan="" rowspan=""><p><strong><u>Posology</u></strong></p></td><td colspan="" rowspan=""><p><strong><u>Duration of treatment</u></strong></p></td></tr><tr><td colspan="" rowspan="2"><p><strong>Cryptococcosis</strong></p></td><td colspan="" rowspan=""><p>- Treatment of cryptococcal meningitis.</p></td><td colspan="" rowspan=""><p>Loading dose: 400 mg on Day 1</p><p>Subsequent dose: 200 mg to 400 mg once daily</p></td><td colspan="" rowspan=""><p>Usually at least 6 to 8 weeks.</p><p>In life threatening infections the daily dose can be increased to 800 mg</p></td></tr><tr><td colspan="" rowspan=""><p>- Maintenance therapy to prevent relapse of cryptococcal meningitis in patients with high risk of recurrence.</p></td><td colspan="" rowspan=""><p>200 mg once daily</p></td><td colspan="" rowspan=""><p>Indefinitely at a daily dose of 200 mg</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Coccidioidomycosis</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>200 mg to 400 mg once daily</p></td><td colspan="" rowspan=""><p>11 months up to 24 months or longer depending on the patient. 800 mg daily may be considered for some infections and especially for meningeal disease</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Invasive candidiasis</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Loading dose: 800 mg on Day 1</p><p>Subsequent dose: 400 mg once daily</p></td><td colspan="" rowspan=""><p>In general, the recommended duration of therapy for candidemia is for 2 weeks after first negative blood culture result and resolution of signs and symptoms attributable to candidemia.</p></td></tr><tr><td colspan="" rowspan="5"><p><strong>Treatment of mucosal candidiasis</strong></p></td><td colspan="" rowspan=""><p>- Oropharyngeal candidiasis</p></td><td colspan="" rowspan=""><p>Loading dose: 200 mg to 400 mg on Day 1</p><p>Subsequent dose: 100 mg to 200 mg once daily</p></td><td colspan="" rowspan=""><p>7 to 21 days (until oropharyngeal candidiasis is in remission).</p><p>Longer periods may be used in patients with severely compromised immune function</p></td></tr><tr><td colspan="" rowspan=""><p>- Oesophageal candidiasis</p></td><td colspan="" rowspan=""><p>Loading dose: 200 mg to 400 mg on Day 1</p><p>Subsequent dose: 100 mg to 200 mg once daily</p></td><td colspan="" rowspan=""><p>14 to 30 days (until oesophageal candidiasis is in remission).</p><p>Longer periods may be used in patients with severely compromised immune function</p></td></tr><tr><td colspan="" rowspan=""><p>- Candiduria</p></td><td colspan="" rowspan=""><p>200 mg to 400 mg once daily</p></td><td colspan="" rowspan=""><p>7 to 21 days. Longer periods may be used in patients with severely compromised immune function.</p></td></tr><tr><td colspan="" rowspan=""><p>- Chronic atrophic candidiasis</p></td><td colspan="" rowspan=""><p>50 mg once daily</p></td><td colspan="" rowspan=""><p>14 days</p></td></tr><tr><td colspan="" rowspan=""><p>- Chronic mucocutaneous candidiasis</p></td><td colspan="" rowspan=""><p>50 mg to 100 mg once daily</p></td><td colspan="" rowspan=""><p>Up to 28 days. Longer periods depending on both the severity of infection or underlying immune compromisation and infection</p></td></tr><tr><td colspan="" rowspan="2"><p><strong>Prevention of relapse of mucosal candidiasis in patients infected with HIV who are at high risk of experiencing relapse</strong></p></td><td colspan="" rowspan=""><p>- Oropharyngeal candidiasis</p></td><td colspan="" rowspan=""><p>100 mg to 200 mg once daily or 200 mg 3 times per week</p></td><td colspan="" rowspan=""><p>An indefinite period for patients with chronic immune suppression</p></td></tr><tr><td colspan="" rowspan=""><p>- Oesophageal candidiasis</p></td><td colspan="" rowspan=""><p>100 mg to 200 mg once daily or 200 mg 3 times per week</p></td><td colspan="" rowspan=""><p>An indefinite period for patients with chronic immune suppression</p></td></tr><tr><td colspan="" rowspan="2"><p><strong>Genital candidiasis</strong></p></td><td colspan="" rowspan=""><p>- Acute vaginal candidiasis</p><p>- Candidal balanitis</p></td><td colspan="" rowspan=""><p>150 mg</p><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Single dose</p></td></tr><tr><td colspan="" rowspan=""><p>- Treatment and prophylaxis of recurrent vaginal candidiasis (4 or more episodes a year).</p></td><td colspan="" rowspan=""><p>150 mg every third day for a total of 3 doses (day 1, 4, and 7) followed by 150 mg once weekly maintenance dose</p></td><td colspan="" rowspan=""><p>Maintenance dose: 6 months.</p></td></tr><tr><td colspan="" rowspan="4"><p><strong>Dermatomycosis</strong></p></td><td colspan="" rowspan=""><p><em>- tinea pedis,</em></p><p><em>- tinea corporis,</em></p><p><em>- tinea cruris,</em></p><p>-&nbsp;<em>candida&nbsp;</em>infections</p></td><td colspan="" rowspan=""><p>150 mg once weekly or 50 mg once daily</p></td><td colspan="" rowspan=""><p>2 to 4 weeks,&nbsp;<em>tinea pedis</em>&nbsp;may require treatment for up to 6 weeks</p></td></tr><tr><td colspan="" rowspan="2"><p><em>- tinea versicolor</em></p></td><td colspan="" rowspan=""><p>300 mg to 400 mg once weekly</p></td><td colspan="" rowspan=""><p>1 to 3 weeks</p></td></tr><tr><td colspan="" rowspan=""><p>50 mg once daily</p></td><td colspan="" rowspan=""><p>2 to 4 weeks</p></td></tr><tr><td colspan="" rowspan=""><p><em>- tinea unguium</em>&nbsp;(<em>onychomycosis</em>)</p></td><td colspan="" rowspan=""><p>150 mg once weekly</p></td><td colspan="" rowspan=""><p>Treatment should be continued until infected nail is replaced (uninfected nail grows in). Regrowth of fingernails and toenails normally requires 3 to 6 months and 6 to 12 months, respectively. However, growth rates may vary widely in individuals, and by age. After successful treatment of long-term chronic infections, nails occasionally remain disfigured.</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Prophylaxis of candidal infections in patients with prolonged neutropenia</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>200 mg to 400 mg once daily</p></td><td colspan="" rowspan=""><p>Treatment should start several days before the anticipated onset of neutropenia and continue for 7 days after recovery from neutropenia after the neutrophil count rises above 1000 cells per mm<sup>3</sup>.</p></td></tr></tbody></table><p>Special populations<br />Elderly<br />Dosage should be adjusted based on the renal function (see &ldquo;Renal impairment&rdquo;).<br />Renal impairment<br />No adjustments in single dose therapy are necessary. In patients (including paediatric<br />population) with impaired renal function who will receive multiple doses of fluconazole, an<br />initial dose of 50 mg to 400 mg should be given, based on the recommended daily dose for<br />the indication. After this initial loading dose, the daily dose (according to indication) should<br />be based on the following table:</p><table cellspacing="0" cellpadding="2" border="1" style="width:691px"><tbody><tr><td colspan="" rowspan=""><p><strong>Creatinine clearance (ml/min)</strong></p></td><td colspan="" rowspan=""><p><strong>Percent of recommended dose</strong></p></td></tr><tr><td colspan="" rowspan=""><p>&gt;50</p></td><td colspan="" rowspan=""><p>100%</p></td></tr><tr><td colspan="" rowspan=""><p>&le;50 (no haemodialysis)</p></td><td colspan="" rowspan=""><p>50%</p></td></tr><tr><td colspan="" rowspan=""><p>Haemodialysis</p></td><td colspan="" rowspan=""><p>100% after each haemodialysis</p></td></tr></tbody></table><p>Patients on regular dialysis should receive 100% of the recommended dose after each<br />dialysis; on non-dialysis days, patients should receive a reduced dose according to their<br />creatinine clearance.<br />Hepatic impairment<br />Limited data are available in patients with hepatic impairment; therefore fluconazole should<br />be administered with caution to patients with liver dysfunction (see sections 4.4 and 4.8).</p><p>Paediatric population<br />A maximum dose of 400 mg daily should not be exceeded in paediatric population.<br />As with similar infections in adults, the duration of treatment is based on the clinical and<br />mycological response. Duracan is administered as a single daily dose.<br />For paediatric patients with impaired renal function, see dosing in &ldquo;Renal impairment&rdquo;. The<br />pharmacokinetics of fluconazole has not been studied in paediatric population with renal<br />insufficiency (for &ldquo;Term newborn infants&rdquo; who often exhibit primarily renal immaturity<br />please see below).<br />Infants, toddlers and children (from 28 days to 11 years old):</p><table cellspacing="0" cellpadding="2" border="1" style="width:691px"><tbody><tr><td colspan="" rowspan=""><p><strong><u>Indication</u></strong></p></td><td colspan="" rowspan=""><p><strong><u>Posology</u></strong></p></td><td colspan="" rowspan=""><p><strong><u>Recommendations</u></strong></p></td></tr><tr><td colspan="" rowspan=""><p>- Mucosal candidiasis</p></td><td colspan="" rowspan=""><p>Initial dose: 6 mg/kg</p><p>Subsequent dose: 3 mg/kg once daily</p></td><td colspan="" rowspan=""><p>Initial dose may be used on the first day to achieve steady state levels more rapidly</p></td></tr><tr><td colspan="" rowspan=""><p>- Invasive candidiasis</p><p>- Cryptococcal meningitis</p></td><td colspan="" rowspan=""><p>Dose: 6 to 12 mg/kg once daily</p></td><td colspan="" rowspan=""><p>Depending on the severity of the disease</p></td></tr><tr><td colspan="" rowspan=""><p>- Maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of recurrence</p></td><td colspan="" rowspan=""><p>Dose: 6 mg/kg once daily</p></td><td colspan="" rowspan=""><p>Depending on the severity of the disease</p></td></tr><tr><td colspan="" rowspan=""><p>- Prophylaxis of&nbsp;<em>Candida</em>&nbsp;in immunocompromised patients</p></td><td colspan="" rowspan=""><p>Dose: 3 to 12 mg/kg once daily</p></td><td colspan="" rowspan=""><p>Depending on the extent and duration of the induced neutropenia (see Adults posology)</p></td></tr></tbody></table><p>Adolescents (from 12 to 17 years old):<br />Depending on the weight and pubertal development, the prescriber would need to assess<br />which posology (adults or children) is the most appropriate. Clinical data indicate that<br />children have a higher fluconazole clearance than observed for adults. A dose of 100, 200<br />and 400 mg in adults corresponds to a 3, 6 and 12 mg/kg dose in children to obtain a<br />comparable systemic exposure.<br />Safety and efficacy for genital candidiasis indication in paediatric population has not been<br />established. Current available safety data for other paediatric indications are described in<br />section 4.8.<br />If treatment for genital candidiasis is imperative in adolescents (from 12 to 17 years old), the<br />posology should be the same as adults posology.<br />Term newborn infants (0 to 27 days):<br />Neonates excrete fluconazole slowly. There are few pharmacokinetic data to support this<br />posology in term newborn infants (see section 5.2).</p><table cellspacing="0" cellpadding="2" border="1" style="width:691px"><tbody><tr><td colspan="" rowspan=""><p><strong><u>Age group</u></strong></p></td><td colspan="" rowspan=""><p><strong><u>Posology</u></strong></p></td><td colspan="" rowspan=""><p><strong><u>Recommendations</u></strong></p></td></tr><tr><td colspan="" rowspan=""><p>Term newborn infants (0 to 14 days)</p></td><td colspan="" rowspan=""><p>The same mg/kg dose as for infants, toddlers and children should be given every 72 hours</p></td><td colspan="" rowspan=""><p>A maximum dose of 12 mg/kg every 72 hours should not be exceeded</p></td></tr><tr><td colspan="" rowspan=""><p>Term newborn infants (from 15 to 27 days)</p></td><td colspan="" rowspan=""><p>The same mg/kg dose as for infants, toddlers and children should be given every 48 hours</p></td><td colspan="" rowspan=""><p>A maximum dose of 12 mg/kg every 48 hours should not be exceeded</p></td></tr></tbody></table><p>Method of Administration:<br />Duracan may be administered either orally or by intravenous infusion, the route being dependent<br />on the clinical state of the patient. On transferring from the intravenous to the oral route, or vice<br />versa, there is no need to change the daily dose.<br />The capsules should be swallowed whole and independent of food intake.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to related azole substances, or to any of the
excipients (see section 6.1).
Coadministration of terfenadine is contraindicated in patients receiving Duracan at multiple
doses of 400 mg per day or higher based upon results of a multiple dose interaction study.
Coadministration of other medicinal products known to prolong the QT interval and which
are metabolised via the cytochrome P450 (CYP) 3A4 such as cisapride, astemizole,
pimozide, quinidine and erythromycin are contraindicated in patients receiving fluconazole
(see sections 4.4 and 4.5).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tinea capitis<br />Fluconazole has been studied for treatment of tinea capitis in children. It was shown not to be<br />superior to griseofulvin and the overall success rate was less than 20%. Therefore, Duracan<br />should not be used for tinea capitis.<br />Cryptococcosis<br />The evidence for efficacy of fluconazole in the treatment of cryptococcosis of other sites (e.g.<br />pulmonary and cutaneous cryptococcosis) is limited, which prevents dosing recommendations.<br />Deep endemic mycosis<br />The evidence for efficacy of fluconazole in the treatment of other forms of endemic mycoses<br />such as paracoccidioidomycosis, lymphocutaneous sporotrichosis and histoplasmosis is<br />limited, which prevents specific dosing recommendations.<br />Renal system<br />Duracan should be administered with caution to patients with renal dysfunction (see section<br />4.2).</p><p>Hepatobiliary system<br />Duracan should be administered with caution to patients with liver dysfunction.<br />Duracan has been associated with rare cases of serious hepatic toxicity including fatalities,<br />primarily in patients with serious underlying medical conditions. In cases of fluconazole<br />associated hepatotoxicity, no obvious relationship to total daily dose, duration of therapy, sex<br />or age of patient has been observed. Fluconazole hepatotoxicity has usually been reversible<br />on discontinuation of therapy.<br />Patients who develop abnormal liver function tests during fluconazole therapy must be<br />monitored closely for the development of more serious hepatic injury.<br />The patient should be informed of suggestive symptoms of serious hepatic effect (important<br />asthenia, anorexia, persistent nausea, vomiting and jaundice). Treatment of fluconazole<br />should be immediately discontinued and the patient should consult a physician.<br />Cardiovascular system<br />Some azoles, including fluconazole, have been associated with prolongation of the QT<br />interval on the electrocardiogram. During post-marketing surveillance, there have been very<br />rare cases of QT prolongation and torsades de pointes in patients taking Duracan. These<br />reports included seriously ill patients with multiple confounding risk factors, such as<br />structural heart disease, electrolyte abnormalities and concomitant treatment that may have<br />been contributory.<br />Duracan should be administered with caution to patients with these potentially proarrhythmic<br />conditions. Coadministration of other medicinal products known to prolong the QT interval<br />and which are metabolised via the cytochrome P450 (CYP) 3A4 are contraindicated (see<br />sections 4.3 and 4.5).</p><p>Halofantrine<br />Halofantrine has been shown to prolong QTc interval at the recommended therapeutic<br />dose and is a substrate of CYP3A4. The concomitant use of fluconazole and<br />halofantrine is therefore not recommended (see section 4.5).<br />Dermatological reactions<br />Patients have rarely developed exfoliative cutaneous reactions, such as Stevens-<br />Johnson syndrome and toxic epidermal necrolysis, during treatment with fluconazole.<br />AIDS patients are more prone to the development of severe cutaneous reactions to<br />many medicinal products. If a rash, which is considered attributable to fluconazole,<br />develops in a patient treated for a superficial fungal infection, further therapy with<br />this medicinal product should be discontinued. If patients with invasive/systemic<br />fungal infections develop rashes, they should be monitored closely and fluconazole<br />discontinued if bullous lesions or erythema multiforme develop.<br />Hypersensitivity<br />In rare cases anaphylaxis has been reported (see section 4.3).<br />Cytochrome P450<br />Fluconazole is a potent CYP2C9 inhibitor and a moderate CYP3A4 inhibitor.<br />Fluconazole is also an inhibitor of CYP2C19. Duracan treated patients who are<br />concomitantly treated with medicinal products with a narrow therapeutic window<br />metabolised through CYP2C9, CYP2C19 and CYP3A4, should be monitored (see<br />section 4.5).<br />Terfenadine<br />The coadministration of fluconazole at doses lower than 400 mg per day with<br />terfenadine should be carefully monitored (see sections 4.3 and 4.5).<br />Excipients<br />Capsules contain lactose monohydrate. Patients with rare hereditary problems of<br />galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption<br />should not take this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant use of the following other medicinal products is contraindicate d:<br />Cisapride:There have been reports of cardiac events including Torsade de Pointes in<br />patients to whom fluconazole and cisapride were coadministered. A controlled study<br />found that concomitant fluconazole 200 mg once daily and cisapride 20 mg four<br />times a day yielded a significant increase in cisapride plasma levels and prolongation<br />of QT interval. Concomitant treatment with fluconazole and cisapride is<br />contraindicated (see section 4.3 ).<br />Terfenadine: Because of the occurrence of serious cardiac dysrhythmias secondary to<br />prolongation of the QTc interval in patients receiving azole antifungals in<br />conjunction with terfenadine, interaction studies have been performed. One study at a<br />200 mg daily dose of fluconazole failed to demonstrate a prolongation in QTc<br />interval. Another study at a 400 mg and 800 mg daily dose of fluconazole<br />demonstrated that fluconazole taken in doses of 400 mg per day or greater<br />significantly increases plasma levels of terfenadine when taken concomitantly. The<br />combined use of fluconazole at doses of 400 mg or greater with terfenadine is<br />contraindicated (see section 4.3). The coadministration of fluconazole at doses lower<br />than 400 mg per day with terfenadine should be carefully monitored.<br />Astemizole: Concomitant administration of fluconazole with astemizole may decrease<br />the clearance of astemizole. Resulting increased plasma concentrations of astemizole<br />can lead to QT prolongation and rare occurrences of torsade depointes.<br />Coadministration of fluconazole and astemizole is contraindicated (see section 4.3).<br />Pimozide: Although not studied in vitro or in vivo, concomitant administration of<br />fluconazole with pimozide may result in inhibition of pimozide metabolism.<br />Increased pimozide plasma concentrations can lead to QT prolongation and rare<br />occurrences of torsade de pointes. Coadministration of fluconazole and pimozide is<br />contraindicated (see section 4.3).<br />Quinidine: Although not studied in vitro or in vivo, concomitant administration of<br />fluconazole with quinidine may result in inhibition of quinidine metabolism. Use of<br />quinidine has been associated with QT prolongation and rare occurrences of torsades<br />de pointes. Coadministration of fluconazole and quinidine is contraindicated (see<br />section 4.3).<br />Erythromycin: Concomitant use of fluconazole and erythromycin has the potential to<br />increase the risk of cardiotoxicity (prolonged QT interval, Torsades de Pointes) and<br />consequently sudden heart death. Coadministration of fluconazole and erythromycin<br />is contraindicated (see section 4.3).</p><p>Concomitant use of the following other medicinal products cannot be recommended:<br />Halofantrine: Fluconazole can increase halofantrine plasma concentration due to an<br />inhibitory effect on CYP3A4. Concomitant use of fluconazole and halofantrine has<br />the potential to increase the risk of cardiotoxicity (prolonged QT interval, torsades de<br />pointes) and consequently sudden heart death. This combination should be avoided<br />(see section 4.4).<br />Concomitant use of the following other medicinal products lead to precautions and<br />dose adjustments:<br />The effect of other medicinal products on fluconazole<br />Rifampicin: Concomitant administration of Duracan and rifampicin resulted in a 25%<br />decrease in the AUC and 20% shorter half-life of fluconazole. In patients receiving<br />concomitant rifampicin, an increase in the Duracan dose should be considered.<br />Interaction studies have shown that when oral fluconazole is coadministered with<br />food, cimetidine, antacids or following total body irradiation for bone marrow<br />transplantation, no clinically significant impairment of fluconazole absorption occurs.<br />The effect of fluconazole on other medicinal products<br />Fluconazole : is a potent inhibitor of cytochrome P450 (CYP) isoenzyme 2C9 and a<br />moderate inhibitor of CYP3A4. Fluconazole is also an inhibitor of the isozyme<br />CYP2C19. In addition to the observed/documented interactions mentioned below,<br />there is a risk of increased plasma concentration of other compounds metabolized by<br />CYP2C9 and CYP3A4 coadministered with fluconazole. Therefore caution should be<br />exercised when using these combinations and the patients should be carefully<br />monitored. The enzyme inhibiting effect of fluconazole persists 4-5 days after<br />discontinuation of fluconazole treatment due to the long half-life of fluconazole (see<br />section 4.3).<br />Alfentanil: During concomitant treatment with fluconazole (400 mg) and intravenous<br />alfentanil (20 &mu;g/kg) in healthy volunteers the alfentanil AUC 10 increased 2-fold,<br />probably through inhibition of CYP3A4.Dose adjustment of alfentanil may be<br />necessary.<br />Amitriptyline, nortriptyline: Fluconazole increases the effect of amitriptyline and<br />nortriptyline. 5-nortriptyline and/or S-amitriptyline may be measured at initiation of<br />the combination therapy and after one week. Dose of amitriptyline/nortriptyline<br />should be adjusted, if necessary</p><p>Amphotericin B: Concurrent administration of fluconazole and amphotericin B in<br />infected normal and immunosuppressed mice showed the following results: a small<br />additive antifungal effect in systemic infection with C. albicans, no interaction in<br />intracranial infection with Cryptococcus neoformans, and antagonism of the two<br />medicinal products in systemic infection with A. fumigatus. The clinical significance<br />of results obtained in these studies is unknown.<br />Anticoagulants: In post-marketing experience, as with other azole antifungals, bleeding<br />events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been<br />reported, in association with increases in prothrombin time in patients receiving<br />fluconazole concurrently with warfarin. During concomitant treatment with fluconazole<br />and warfarin the prothrombin time was prolonged up to 2- fold, probably due to an<br />inhibition of the warfarin metabolism through CYP2C9. In patients receiving coumarintype<br />anticoagulants concurrently with fluconazole the prothrombin time should be<br />carefully monitored. Dose adjustment of warfarin may be necessary.<br />Benzodiazepines (short acting), i.e. midazolam, triazolam: Following oral administration<br />of midazolam, fluconazole resulted in substantial increases in midazolam<br />concentrations and psychomotor effects. Concomitant intake of fluconazole 200 mg<br />and midazolam 7.5 mg orally increased the midazolam AUC and half-life 3.7-fold<br />and 2.2-fold, respectively. Fluconazole 200 mg daily given concurrently with<br />triazolam 0.25 mg orally increased the triazolam AUC and half-life 4.4-fold and 2.3-<br />fold, respectively. Potentiated and prolonged effects of triazolam have been observed<br />at concomitant treatment with fluconazole. If concomitant benzodiazepine therapy is<br />necessary in patients being treated with fluconazole, consideration should be given to<br />decreasing the benzodiazepine dose, and the patients should be appropriately<br />monitored.<br />Carbamazepine: Fluconazole inhibits the metabolism of carbamazepine and an<br />increase in serum carbamazepine of 30% has been observed. There is a risk of<br />developing carbamazepine toxicity. Dose adjustment of carbamazepine may be<br />necessary depending on concentration measurements/effect.<br />Calcium channel blockers: Certain calcium channel antagonists (nifedipine, isradipine,<br />amlodipine, verapamil and felodipine) are metabolized by CYP3A4. Fluconazole has<br />the potential to increase the systemic exposure of the calcium channel antagonists.<br />Frequent monitoring for adverse events is recommended.<br />Celecoxib: During concomitant treatment with fluconazole (200 mg daily) and<br />celecoxib (200 mg) the celecoxib Cmax and AUC increased by 68% and 134%,<br />respectively. Half of the celecoxib dose may be necessary when combined with<br />fluconazole.</p><p>Cyclophosphamide: Combination therapy with cyclophosphamide and fluconazole<br />results in an increase in serum bilirubin and serum creatinine. The combination may<br />be used while taking increased consideration to the risk of increased serum bilirubin<br />and serum creatinine.<br />Fentanyl: One fatal case of fentanyl intoxication due to possible fentanyl fluconazole<br />interaction was reported. Furthermore, it was shown in healthy volunteers that<br />fluconazole delayed the elimination of fentanyl significantly. Elevated fentanyl<br />concentration may lead to respiratory depression. Patients should be monitored<br />closely for the potential risk of respiratory depression. Dosage adjustment of fentanyl<br />may be necessary.<br />HMG CoA reductase inhibitors: The risk of myopathy and rhabdomyolysis increases<br />when fluconazole is coadministered with HMG-CoA reductase inhibitors metabolised<br />through CYP3A4, such as atorvastatin and simvastatin, or through CYP2C9, such as<br />fluvastatin. If concomitant therapy is necessary, the patient should be observed for<br />symptoms of myopathy and rhabdomyolysis and creatinine kinase should be<br />monitored. HMG-CoA reductase inhibitors should be discontinued if a marked<br />increase in creatinine kinase is observed or myopathy/rhabdomyolysis is diagnosed or<br />suspected.<br />Immunosuppresors (i.e. ciclosporin, everolimus, sirolimus and tacrolimus):<br />Ciclosporin: Fluconazole significantly increases the concentration and AUC of<br />ciclosporin. During concomitant treatment with fluconazole 200 mg daily and<br />ciclosporin (2.7 mg/kg/day) there was a 1.8-fold increase in ciclosporin AUC. This<br />combination may be used by reducing the dose of ciclosporin depending on<br />ciclosporin concentration.<br />Everolimus: Although not studied in vivo or in vitro, fluconazole may increase serum<br />concentrations of everolimus through inhibition of CYP3A4.<br />Sirolimus: Fluconazole increases plasma concentrations of sirolimus presumably by<br />inhibiting the metabolism of sirolimus via CYP3A4 and P-glycoprotein. This<br />combination may be used with a dose adjustment of sirolimus depending on the<br />effect/concentration measurements.<br />Tacrolimus: Fluconazole may increase the serum concentrations of orally<br />administered tacrolimus up to 5 times due to inhibition of tacrolimus metabolism<br />through CYP3A4 in the intestines. No significant pharmacokinetic changes have been<br />observed when tacrolimus is given intravenously. Increased tacrolimus levels have<br />been associated with nephrotoxicity. Dose of orally administered tacrolimus should<br />be decreased depending on tacrolimus concentration.</p><p>Losartan: Fluconazole inhibits the metabolism of losartan to its active metabolite (E-<br />31 74) which is responsible for most of the angiotensin Il-receptor antagonism which<br />occurs during treatment with losartan. Patients should have their blood pressure<br />monitored continuously.<br />Methadone: Fluconazole may enhance the serum concentration of methadone. Dose<br />adjustment of methadone may be necessary.<br />Non-steroidal anti-inflammatory drugs: The Cmax and AUC of flurbiprofen were<br />increased by 23% and 81%, respectively, when coadministered with fluconazole<br />compared to administration of flurbiprofen alone. Similarly, the Cmax and AUC of<br />the pharmacologically active isomer [S-(+)-ibuprofen] was increased by 15% and<br />82%, respectively, when fluconazole was coadministered with racemic ibuprofen<br />(400 mg) compared to administration of racemic ibuprofen alone.<br />Although not specifically studied, fluconazole has the potential to increase the<br />systemic exposure of other NSAIDs that are metabolized by CYP2C9 (e.g. naproxen,<br />lornoxicam, meloxicam, diclofenac). Frequent monitoring for adverse events and<br />toxicity related to NSAIDs is recommended. Adjustment of dose of NSAIDs may be<br />needed.<br />Phenytoin: Fluconazole inhibits the hepatic metabolism of phenytoin. Concomitant<br />repeated administration of 200 mg fluconazole and 250 mg phenytoin intravenously,<br />caused an increase of the phenytoin AUC24 by 75% and Cmin by 128%. With<br />coadministration, serum phenytoin concentration levels should be monitored in order<br />to avoid phenytoin toxicity.<br />Prednisone: There was a case report that a liver-transplanted patient treated with<br />prednisone developed acute adrenal cortex insufficiency when a three month therapy<br />with fluconazole was discontinued. The discontinuation of fluconazole presumably<br />caused an enhanced CYP3A4 activity which led to increased metabolism of<br />prednisone. Patients on long-term treatment with fluconazole and prednisone should<br />be carefully monitored for adrenal cortex insufficiency when fluconazole is<br />discontinued.<br />Rifabutin: Fluconazole increases serum concentrations of rifabutin, leading to<br />increase in the AUC of rifabutin up to 80%. There have been reports of uveitis in<br />patients to whom fluconazole and rifabutin were coadministered. In combination<br />therapy, symptoms of rifabutin toxicity should be taken into consideration.</p><p>Saquinavir: Fluconazole increases the AUC and Cmax of saquinavir with<br />approximately 50% and 55% respectively, due to inhibition of saquinavir&#39;s hepatic<br />metabolism by CYP3A4 and inhibition of P-glycoprotein. Interaction with<br />saquinavir/ritonavir has not been studied and might be more marked. Dose adjustment<br />of saquinavir may be necessary.<br />Sulfonylureas: Fluconazole has been shown to prolong the serum half-life of<br />concomitantly administered oral sulfonylureas (e.g., chlorpropamide, glibenclamide,<br />glipizide, tolbutamide) in healthy volunteers. Frequent monitoring of blood glucose<br />and appropriate reduction of sulfonylurea dose is recommended during<br />coadministration.<br />Theophylline: In a placebo controlled interaction study, the administration of<br />fluconazole 200 mg for 14 days resulted in an 18% decrease in the mean plasma<br />clearance rate of theophylline. Patients who are receiving high dose theophylline or<br />who are otherwise at increased risk for theophylline toxicity should be observed for<br />signs of theophylline toxicity while receiving fluconazole. Therapy should be<br />modified if signs of toxicity develop.<br />Vinca alkaloids: Although not studied, fluconazole may increase the plasma levels of<br />the vinca alkaloids (e.g. vincristine and vinblastine) and lead to neurotoxicity, which<br />is possibly due to an inhibitory effect on CYP3A4.<br />Vitamin A: Based on a case-report in one patient receiving combination therapy with<br />all-trans-retinoid acid (an acid form of vitamin A) and fluconazole, CNS related<br />undesirable effects have developed in the form of pseudotumour cerebri, which<br />disappeared after discontinuation of fluconazole treatment. This combination may be<br />used but the incidence of CNS related undesirable effects should be borne in mind.</p><p>Voriconazole: (CYP2C9 and CYP3A4 inhibitor): Coadministration of oral voriconazole (400<br />mg Q12h for 1 day, then 200 mg Q12h for 2.5 days) and oral fluconazole (400 mg on day 1,<br />then 200 mg Q24h for 4 days) to 8 healthy male subjects resulted in an increase in Cmax and<br />AUC of voriconazole by an average of 57% (90% CI: 20%, 107%) and 79% (90% CI:<br />40%, 128%), respectively. The reduced dose and/or frequency of voriconazole and<br />fluconazole that would eliminate this effect have not been established. Monitoring for<br />voriconazole associated adverse events is recommended if voriconazole is used sequentially<br />after fluconazole.<br />Zidovudine: Fluconazole increases Cmax and AUC of zidovudine by 84% and 74%,<br />respectively, due to an approx. 45% decrease in oral zidovudine clearance. The half- life of<br />zidovudine was likewise prolonged by approximately 128% following combination therapy<br />with fluconazole. Patients receiving this combination should be monitored for the<br />development of zidovudine-related adverse reactions. Dose reduction of zidovudine may be<br />considered.<br />Azithromycin: An open-label, randomized, three-way crossover study in 18 healthy subjects<br />assessed the effect of a single 1200 mg oral dose of azithromycin on the pharmacokinetics of<br />a single 800 mg oral dose of fluconazole as well as the effects of fluconazole on the<br />pharmacokinetics of azithromycin. There was no significant pharmacokinetic interaction<br />between fluconazole and azithromycin.<br />Oral contraceptives: Two pharmacokinetic studies with a combined oral contraceptive have<br />been performed using multiple doses of fluconazole. There were no relevant effects on<br />hormone level in the 50 mg fluconazole study, while at 200 mg daily, the AUCs of ethinyl<br />estradiol and levonorgestrel were increased 40% and 24%, respectively. Thus, multiple dose<br />use of fluconazole at these doses is unlikely to have an effect on the efficacy of the combined<br />oral contraceptive.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Data from several hundred pregnant women treated with standard doses (&lt;200 mg/day) of<br />fluconazole, administered as a single or repeated dose in the first trimester, show no<br />undesirable effects in the foetus.<br />There have been reports of multiple congenital abnormalities (including brachycephalia, ears<br />dysplasia, giant anterior fontanelle, femoral bowing and radio- humeral synostosis) in infants<br />whose mothers were treated for at least three or more months with high doses (400-800 mg<br />daily) of fluconazole for coccidioidomycosis. The relationship between fluconazole use and<br />these events is unclear.<br />Studies in animals have shown reproductive toxicity (see section 5.3).<br />Fluconazole in standard doses and short-term treatments should not be used in pregnancy<br />unless clearly necessary.<br />Fluconazole in high dose and/or in prolonged regimens should not be used during pregnancy<br />except for potentially life-threatening infections.<br />Breast-feeding<br />Fluconazole passes into breast milk to reach concentrations lower than those in plasma.<br />Breast-feeding may be maintained after a single use of a standard dose 200 mg fluconazole or<br />less. Breast-feeding is not recommended after repeated use or after high dose fluconazole.<br />Fertility<br />Fluconazole did not affect the fertility of male or female rats (see section 5.3)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies have been performed on the effects of Duracan on the ability to drive or<br />use machines.<br />Patients should be warned about the potential for dizziness or seizures (see section<br />4.8) while taking Duracan and should be advised not to drive or operate machines if<br />any of these symptoms occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most frequently (&gt;1/10) reported adverse reactions are headache, abdominal<br />pain, diarrhoea, nausea, vomiting, alanine aminotransferase increased, aspartate<br />aminotransferase increased, blood alkaline phosphatase increased and rash.<br />The following adverse reactions have been observed and reported during treatment<br />with Duracan with the following frequencies: Very common ( 1/10); common (<br />1/100 to &lt;1/10); uncommon ( 1/1,000 to &lt;1/100); rare ( 1/10,000 to &lt;1/1,000);<br />very rare (&lt;1/10,000), not known (cannot be estimated from the available data).</p><table cellspacing="0" cellpadding="2" border="1" style="width:691px"><tbody><tr></tr><tr><td colspan="" rowspan=""><p><strong>System Organ Class</strong></p></td><td colspan="" rowspan=""><p><strong>Common</strong></p></td><td colspan="" rowspan=""><p><strong>Uncommon</strong></p></td><td colspan="" rowspan=""><p><strong>Rare</strong></p></td><td colspan="" rowspan=""><p><strong>Not Known</strong></p></td></tr><tr><td colspan="" rowspan=""><p><strong>Blood and the lymphatic system disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Anaemia</p></td><td colspan="" rowspan=""><p>Agranulocytosis, leukopenia, thrombocytopenia, neutropenia</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Immune system disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Anaphylaxis</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Metabolism and nutrition disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Decreased appetite</p></td><td colspan="" rowspan=""><p>Hypercholesterolaemia, hypertriglyceridaemia, hypokalaemia</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Psychiatric disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Somnolence, insomnia</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Nervous system disorders</strong></p></td><td colspan="" rowspan=""><p>Headache</p></td><td colspan="" rowspan=""><p>Silures, paraesthesia, dizziness, taste perversion</p></td><td colspan="" rowspan=""><p>Tremor</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Ear and labyrinth disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Vertigo</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Cardiac disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Torsade de pointes (see section 4.4), QT prolongation (see section 4.4)</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Gastrointestinal disorders</strong></p></td><td colspan="" rowspan=""><p>Abdominal pain, vomiting, diarrhoea, nausea</p></td><td colspan="" rowspan=""><p>Constipation dyspepsia, flatulence, dry mouth</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Hepatobiliary disorders</strong></p></td><td colspan="" rowspan=""><p>Alanine aminotransferase increased (see section 4.4), aspartate aminotransferase increased (see section 4.4), blood alkaline phosphatase increased (see section 4.4)</p></td><td colspan="" rowspan=""><p>Cholestasis (see section 4.4), jaundice (see section 4.4), bilirubin increased (see section 4.4)</p></td><td colspan="" rowspan=""><p>Hepatic failure (see section 4.4), hepatocellular necrosis (see section 4.4), hepatitis (see section 4.4), hepatocellular damage (see section 4.4)</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td colspan="" rowspan=""><p>Rash (see section 4.4)</p></td><td colspan="" rowspan=""><p>Drug eruption* (see section 4.4), urticaria (see section 4.4), pruritus, increased sweating</p></td><td colspan="" rowspan=""><p>Toxic epidermal necrolysis, (see section 4.4), Stevens-Johnson syndrome (see section 4.4), acute generalised exanthematous-pustulosis (see section 4.4), dermatitis exfoliative, angioedema, face oedema, alopecia</p></td><td colspan="" rowspan=""><p>Drug reaction with eosinophilia and systemic symptoms (DRESS)</p></td></tr><tr><td colspan="" rowspan=""><p><strong>Musculoskeletal and connective tissue disorders</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Myalgia</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p><strong>General disorders and administration site conditions</strong></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p>Fatigue, malaise, asthenia, fever</p></td><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan="">&nbsp;</td></tr></tbody></table><p>Paediatric Population<br />The pattern and incidence of adverse reactions and laboratory abnormalities<br />recorded during paediatric clinical trials, excluding the genital candidiasis<br />indication, are comparable to those seen in adults.</p><p>Reporting of suspected adverse reactions<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222,<br />Ext: 2317-2356-2340.<br />Toll free phone: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There have been reports of overdose with Duracan and hallucination and<br />paranoid behaviour have been concomitantly reported.<br />In the event of overdose, symptomatic treatment (with supportive measures and<br />gastric lavage if necessary) may be adequate.<br />Fluconazole is largely excreted in the urine; forced volume diuresis would<br />probably increase the elimination rate. A three-hour haemodialysis session<br />decreases plasma levels by approximately 50%.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Antimycotics for systemic use, triazole derivatives, ATC code: J02AC01.<br />Mode of action<br />Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition<br />of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential<br />step in fungal ergosterol biosynthesis. The accumulation of 14 alpha-methyl sterols<br />correlates with the subsequent loss of ergosterol in the fungal cell membrane and<br />may be responsible for the antifungal activity of fluconazole. Fluconazole has been<br />shown to be more selective for fungal cytochrome P-450 enzymes than for various<br />mammalian cytochrome P-450 enzyme systems.<br />Fluconazole 50 mg daily given up to 28 days has been shown not to effect<br />testosterone plasma concentrations in males or steroid concentration in females of<br />child-bearing age. Fluconazole 200 mg to 400 mg daily has no clinically significant<br />effect on endogenous steroid levels or on ACTH stimulated response in healthy male<br />volunteers. Interaction studies with antipyrine indicate that single or multiple doses of<br />fluconazole 50 mg do not affect its metabolism.<br />Susceptibility in vitro<br />In vitro, fluconazole displays antifungal activity against most clinically common<br />Candida species (including C. albicans, C. parapsilosis, C. tropicalis). C. glabrata<br />shows a wide range of susceptibility while C. krusei is resistant to fluconazole.<br />Fluconazole also exhibits activity in vitro against Cryptococcus neoformans and<br />Cryptococcus. gattii as well as the endemic moulds Blastomyces dermatiditis,<br />Coccidioides immitis, Histoplasma capsulatum and Paracoccidioides brasiliensis</p><p>PK/PD relationship<br />In animal studies, there is a correlation between MIC values and efficacy against experimental<br />mycoses due to Candida spp. In clinical studies, there is an almost 1:1 linear relationship<br />between the AUC and the dose of fluconazole. There is also a direct though imperfect<br />relationship between the AUC or dose and a successful clinical response of oral candidosis and<br />to a lesser extent candidaemia to treatment. Similarly cure is less likely for infections caused by<br />strains with a higher fluconazole MIC.<br />Mechanism(s) of resistance<br />Candida spp have developed a number of resistance mechanisms to azole antifungal agents.<br />Fungal strains which have developed one or more of these resistance mechanisms are known to<br />exhibit high minimum inhibitory concentrations (MICs) to fluconazole which impacts adversely<br />efficacy in vivo and clinically.<br />There have been reports of superinfection with Candida species other than C. albicans, which<br />are often inherently not susceptible to fluconazole (e.g. Candida krusei). Such cases may require<br />alternative antifungal therapy.<br />Breakpoints (according to EUCAST)<br />Based on analyses of pharmacokinetic/pharmacodynamic (PK/PD) data, susceptibility in vitro<br />and clinical response EUCAST-AFST (European Committee on Antimicrobial susceptibility<br />Testing-subcommittee on Antifungal Susceptibility Testing) has determined breakpoints for<br />fluconazole for Candida species (EUCAST Fluconazole rational document (2007)-version 2).<br />These have been divided into non- species related breakpoints; which have been determined<br />mainly on the basis of PK/PD data and are independent of MIC distributions of specific species,<br />and species related breakpoints for those species most frequently associated with human<br />infection. These breakpoints are given in the table below:</p><table cellspacing="0" cellpadding="2" border="1" style="width:691px"><tbody><tr><td colspan="" rowspan=""><p>Antifungal</p></td><td colspan="5" rowspan=""><p>Species-related breakpoints (S&le;/R&gt;)</p></td><td colspan="" rowspan=""><p>Non-species related breakpoints<sup>A</sup></p><p>S&le;/R&gt;</p></td></tr><tr><td colspan="" rowspan=""><p>&nbsp;</p></td><td colspan="" rowspan=""><p><em>Candida albicans</em></p></td><td colspan="" rowspan=""><p><em>Candida glabrata</em></p></td><td colspan="" rowspan=""><p><em>Candida krusei</em></p></td><td colspan="" rowspan=""><p><em>Candida parapsilosis</em></p></td><td colspan="" rowspan=""><p><em>Candida tropicalis</em></p></td><td colspan="" rowspan=""><p>&nbsp;</p></td></tr><tr><td colspan="" rowspan=""><p>Fluconazole</p></td><td colspan="" rowspan="" style="vertical-align:middle"><p>2/4</p></td><td colspan="" rowspan="" style="vertical-align:middle"><p>IE</p></td><td colspan="" rowspan="" style="vertical-align:middle"><p>--</p></td><td colspan="" rowspan="" style="vertical-align:middle"><p>2/4</p></td><td colspan="" rowspan="" style="vertical-align:middle"><p>2/4</p></td><td colspan="" rowspan=""><p>2/4</p></td></tr></tbody></table><p>S = Susceptible, R = Resistant<br />A = Non-species related breakpoints have been determined mainly on the basis of PK/PD<br />data and are independent of MIC distributions of specific species. They are for use only for<br />organisms that do not have specific breakpoints.<br />-- = Susceptibility testing not recommended as the species is a poor target for therapy with<br />the medicinal product.<br />IE = There is insufficient evidence that the species in question is a good target for therapy<br />with the medicinal product</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of fluconazole are similar following administration by the<br />intravenous or oral route.<br />Absorption<br />After oral administration fluconazole is well absorbed, and plasma levels (and systemic<br />bioavailability) are over 90% of the levels achieved after intravenous administration. Oral<br />absorption is not affected by concomitant food intake. Peak plasma concentrations in the<br />fasting state occur between 0.5 and 1.5 hours post-dose. Plasma concentrations are<br />proportional to dose. Ninety percent steady state levels are reached by day 4-5 with multiple<br />once daily dosing. Administration of a loading dose (on day 1) of twice the usual daily dose<br />enables plasma levels to approximate to 90% steady-state levels by day 2.<br />Distribution<br />The apparent volume of distribution approximates to total body water. Plasma protein<br />binding is low (11-12%).<br />Fluconazole achieves good penetration in all body fluids studied. The levels of fluconazole in<br />saliva and sputum are similar to plasma levels. In patients with fungal meningitis,<br />fluconazole levels in the CSF are approximately 80% the corresponding plasma levels.</p><p>stratum corneum, epidermis-dermis and eccrine sweat. Fluconazole accumulates in the<br />stratum corneum. At a dose of 50 mg once daily, the concentration of fluconazole after 12<br />days was 73 &mu;g/g and 7 days after cessation of treatment the concentration was still 5.8<br />&mu;g/g. At the 150 mg once-a-week dose, the concentration of fluconazole in stratum<br />corneum on day 7 was 23.4 &mu;g/g and 7 days after the second dose was still 7.1 &mu;g/g.<br />Concentration of fluconazole in nails after 4 months of 150 mg once-a-week dosing was<br />4.05 &mu;g/g in healthy and 1.8 &mu;g/g in diseased nails; and, fluconazole was still measurable in<br />nail samples 6 months after the end of therapy.<br />Biotransformation<br />Fluconazole is metabolised only to a minor extent. Of a radioactive dose, only 11% is<br />excreted in a changed form in the urine. Fluconazole is a selective inhibitor of the isozymes<br />CYP2C9 and CYP3A4 (see section 4.5). Fluconazole is also an inhibitor of the isozyme<br />CYP2C19.<br />Excretion<br />Plasma elimination half-life for fluconazole is approximately 30 hours. The major route of<br />excretion is renal, with approximately 80% of the administered dose appearing in the urine<br />as unchanged medicinal product. Fluconazole clearance is proportional to creatinine<br />clearance. There is no evidence of circulating metabolites.<br />The long plasma elimination half-life provides the basis for single dose therapy for vaginal<br />candidiasis, once daily and once weekly dosing for other indications.<br />Pharmacokinetics in renal impairment<br />In patients with severe renal insufficiency, (GFR&lt; 20 ml/min) half life increased from 30 to<br />98 hours. Consequently, reduction of the dose is needed. Fluconazole is removed by<br />haemodialysis and to a lesser extent by peritoneal dialysis. After three hours of<br />haemodialysis session, around 50% of fluconazole is eliminated from blood.<br />Pharmacokinetics in chlidren<br />Pharmacokinetic data were assessed for 113 paediatric patients from 5 studies; 2 singledose<br />studies, 2 multiple-dose studies, and a study in premature neonates. Data from one<br />study were not interpretable due to changes in formulation pathway through the study.<br />Additional data were available from a compassionate use study.</p><p>After administration of 2-8 mg/kg fluconazole to children between the ages of 9 months to 15<br />years, an AUC of about 38 &mu;g&bull;h/ml was found per 1 mg/kg dose units. The average<br />fluconazole plasma elimination half-life varied between 15 and 18 hours and the distribution<br />volume was approximately 880 ml/kg after multiple doses. A higher fluconazole plasma<br />elimination half-life of approximately 24 hours was found after a single dose. This is<br />comparable with the fluconazole plasma elimination half- life after a single administration of<br />3 mg/kg i.v. to children of 11 days-11 months old. The distribution volume in this age group<br />was about 950 ml/kg.<br />Experience with fluconazole in neonates is limited to pharmacokinetic studies in premature<br />newborns. The mean age at first dose was 24 hours (range 9-36 hours) and mean birth weight<br />was 0.9 kg (range 0.75-1.10 kg) for 12 pre-term neonates of average gestation around 28<br />weeks. Seven patients completed the protocol; a maximum of five 6 mg/kg intravenous<br />infusions of fluconazole were administered every 72 hours. The mean half-life (hours) was<br />74 (range 44-185) on day 1 which decreased, with time to a mean of 53 (range 30-131) on<br />day 7 and 47 (range 27-68) on day 13. The area under the curve (microgram.h/ml) was 271<br />(range 173-385) on<br />day 1 and increased with a mean of 490 (range 292-734) on day 7 and decreased with a mean<br />of 360 (range 167-566) on day 13. The volume of distribution (ml/kg) was<br />1183 (range 1070-1470) on day 1 and increased, with time, to a mean of 1184 (range<br />510-2130) on day 7 and 1328 (range 1040-1680) on day 13.<br />Pharmacokinetics in elderly<br />A pharmacokinetic study was conducted in 22 subjects, 65 years of age or older receiving a<br />single 50 mg oral dose of fluconazole. Ten of these patients were concomitantly receiving<br />diuretics. The Cmax was 1.54 &mu;g/ml and occurred at 1.3 hours post-dose. The mean AUC was<br />76.4 &plusmn; 20.3 &mu;g&bull;h/ml, and the mean terminal half-life was 46.2 hours. These pharmacokinetic<br />parameter values are higher than analogous values reported for normal young male volunteers.<br />Coadministation of diuretics did not significantly alter AUC or Cmax. In addition, creatinine<br />clearance (74 ml/min), the percent of medicinal product recovered unchanged in urine (0-24 h,<br />22%) and the fluconazole renal clearance estimates (0.124 ml/min/kg) for the elderly were<br />generally lower than those of younger volunteers. Thus, the alteration of fluconazole disposition<br />in the elderly appears to be related to reduced renal function characteristics of this group.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects in non-clinical studies were observed only at exposures considered sufficiently in<br />excess of the human exposure indicating little relevance to clinical use.<br />Carcinogenesis<br />Fluconazole showed no evidence of carcinogenic potential in mice and rats treated orally for<br />24 months at doses of 2.5, 5, or 10 mg/kg/day (approximately 27 times the recommended<br />human dose). Male rats treated with 5 and 10 mg/kg/day had an increased incidence of<br />hepatocellular adenomas.<br />Reproductive toxicity<br />Fluconazole did not affect the fertility of male or female rats treated orally with daily doses<br />of 5, 10, or 20 mg/kg or with parenteral doses of 5, 25, or 75 mg/kg.<br />There were no foetal effects at 5 or 10 mg/kg; increases in foetal anatomical variants<br />(supernumerary ribs, renal pelvis dilation) and delays in ossification were observed at 25 and<br />50 mg/kg and higher doses. At doses ranging from 80 mg/kg to 320 mg/kg embryolethality in<br />rats was increased and foetal abnormalities included wavy ribs, cleft palate, and abnormal<br />cranio-facial ossification.<br />The onset of parturition was slightly delayed at 20 mg/kg orally and dystocia and<br />prolongation of parturition were observed in a few dams at 20 mg/kg and 40 mg/kg<br />intravenously. The disturbances in parturition were reflected by a slight increase in the<br />number of still-born pups and decrease of neonatal survival at these dose levels. These effects<br />on parturition are consistent with the species specific oestrogen- lowering property produced<br />by high doses of fluconazole. Such a hormone change has not been observed in women<br />treated with fluconazole (see section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose Anhydrous<br />&bull; Crospovidone NF<br />&bull; Magnesium Stearate<br />&bull; Colloidal Silicon Dioxide (Aerosil 200)<br />&bull; ECG- Duracan (1,Blue/Blue)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Alu-PVC/PVDC Blister</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company,
PO Box 6267, 
Industrial area Phase V, 
JEDDAH, 
Saudi Arabia, 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jan-2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>